Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.

Abstract : BACKGROUND: Multiple myeloma (MM) is still a fatal plasma cell cancer. Novel compounds are currently clinically tested as a single agent in relapsing patients, but in best cases with partial response of a fraction of patients, emphasising the need to design tools predicting drug efficacy. Histone deacetylase inhibitors (HDACi) are anticancer agents targeting epigenetic regulation of gene expression and are in clinical development in MM. METHODS: To create a score predicting HDACi efficacy, five MM cell lines were treated with trichostatin A (TSA) and gene expression profiles were determined. RESULTS: The expression of 95 genes was found to be upregulated by TSA, using paired supervised analysis with Significance Analysis of Microarrays software. Thirty-seven of these 95 genes had prognostic value for overall survival in a cohort of 206 newly diagnosed MM patients and their prognostic information was summed up in a histone acetylation score (HA Score); patients with the highest HA Score had the shorter overall survival. It is worth noting that MM cell lines or patients' primary MM cells with a high HA Score had a significant higher sensitivity to TSA, valproic acid, panobinostat or vorinostat. CONCLUSION: In conclusion, the HA Score allows identification of MM patients with poor survival, who could benefit from HDACi treatment.
Type de document :
Article dans une revue
British Journal of Cancer, Cancer Research UK, 2013, 109 (3), pp.676-85. 〈10.1038/bjc.2013.392〉
Liste complète des métadonnées

Littérature citée [68 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00906782
Contributeur : Monique Frei <>
Soumis le : mercredi 4 juin 2014 - 14:44:27
Dernière modification le : vendredi 20 octobre 2017 - 01:17:36
Document(s) archivé(s) le : jeudi 4 septembre 2014 - 10:41:53

Fichier

merged_1371674987_-_2013.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Jérôme Moreaux, Thierry Rème, Wim Leonard, Jean-Luc Veyrune, Guilhem Requirand, et al.. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.. British Journal of Cancer, Cancer Research UK, 2013, 109 (3), pp.676-85. 〈10.1038/bjc.2013.392〉. 〈inserm-00906782〉

Partager

Métriques

Consultations de la notice

368

Téléchargements de fichiers

291